SlideShare uma empresa Scribd logo
1 de 16
Baixar para ler offline
The simplified Whole Embryo Culture
the throughput increase of a validated tool
for developmental toxicology

Marta Barenys
CERETOX – Centre de Recerca en Toxicologia, Parc Científic de Barcelona
IUF – Leibniz Research Institute for Environmental Medicine, Düsseldorf
Outline
Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

Summary
Whole Embryo Culture (WEC)
developmental toxicology

Whole Embryo Culture
Implantation

DB-ALM report

WEC
WEC
Fetal - period

Organogenesis

Simplified WEC Assay

Summary

0

2

4

6

8

10

12

14

16

18

Gestational
Day

Establishment:

New, 1978. Biol Rev Camb Philos Soc

REACH - Registration, Evaluation,
Authorization and Restriction of Chemicals
ECVAM Validation: Genschow et al., 2002. Altern Lab Anim
Piersma et al., 2004. Altern Lab Anim
ECVAM DB-ALM Protocol n.123 – Method of Piersma

20 21
[1]
Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

Summary

[1]:Flick and Klug, 2006. Curr Pharm Des
48 h
Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

Summary

Isolation

Culture

Evaluation

Gestational Day 9.5

37ºC temperature
25 rpm rotation

Endpoints:

Tested substances added
to the culture medium
Oxygenation

Viability
Growth
Differentiation
Malformations
„a demanding procedure which might be unsuitable for routine use as a first step in a
large scale screening program“

Evaluation
Whole Embryo Culture

Crown-rump length
DB-ALM report

Somite number
Simplified WEC Assay

Summary

Total Morphological Score:

Malformations

ICmax mal
ICNOEC TMS

ECVAM Prediction Model 2

IC50 3T3

A.
B.
C.
D.
E.
F.
G.
H.
J.
K.
L.
M.
N.
P.
Q.
R.

Yolk sac and blood vessels
Allantois
Flexion
Heart
Caudal neural tube
Hind brain
Mid brain
Fore brain
Otic system
Optic system
Olfactory system
Branchial bars
Maxillary process
Mandibular process
Fore limb
Hind limb

I > II & III = non embryotoxic
II > I & III = weak embryotoxic
III > I & II = strong embryotoxic
[2]

Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

Summary

1 mm

CERETOX
Developmental toxicity studies:
- among compounds of the same family
- among parent compound and metabolites

de Jong et al., 2011 Toxicol Appl Pharmacol
Barenys et al., 2012 Reprod Toxicol
Boix et al., in preparation
[2]: Barenys et al., 2012. Reprod Toxicol
European Partnership for Alternative Approaches to Animal Testing (EPAA)
Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

Summary

Questionnaire survey - Alternative methods for reproductive toxicity testing

Aim:
to investigate the real use of each alternative method among industries

Participants:
11 large international pharmaceutical and chemical companies

ECVAM DataBase service on Alternative Methods to animal experimentation (DB-ALM)

DB-ALM reproductive toxicity report 2011[3]

[3]:http://ec.europa.eu/enterprise/epaa/2_activities/2_3_comm_and_
dissem/report_alternative_methods_reproductive_toxicity_testing.pdf
DB-ALM report
Alternative methods for reproductive toxicity testing
Whole Embryo Culture

39

21

9

total

DB-ALM report

developmental toxicity

really used
ZFET - Zebrafish Embryo Test
EST - Embryonic Stem Cell Test
WEC - Whole Embryo Culture

Simplified WEC Assay

Summary

WEC:

6 companies
substance related mechanistic studies
screening or priority testing
regulatory purposes
studies on species differences (rat/rabbit)

part of integrated testing strategy or stand-alone test
[3]:http://ec.europa.eu/enterprise/epaa/2_activities/2_3_comm_and_
dissem/report_alternative_methods_reproductive_toxicity_testing.pdf
Advantages:
Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

Whole organism
Same species than in in vivo reproductive toxicity assays
High predictivity
High reproducibility

Summary

Disadvantages:
High expertise required
High cost
Labor intensive
Low throughput

Should I
stay or
should I go?
Simplified WEC Assay [4]
Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

All compounds
Spinal cord ≥ 4.83?

Aims:
↑ throughput
↓ animal use
without reducing predictivity

Yes

No

Heart ≥ 4.75?

Teratogen

Yes

No

Nonteratogen

N° of somites ≥ 22.575?
Summary

Simplification achieved by:
No
Statistical prediction model supported by
Teratogen
one test concentration
two structural endpoints (spinal cord – heart)
one growth endpoint (n. of somites)

Yes
Nonteratogen

Prediction model built with data from:
59 compounds (33 teratogens and 26 nonteratogens)

70

+11 compounds ( 5t & 6nt) for independent validation
[4]: Zhang et al., 2012. Toxicological Sciences
Simplified WEC Assay

Nonteratogens

Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

Summary

Results from 3 independent laboratories
Average scores obtained from two or more experiments with six embryos per experiment

7 missclassified out of 26

[4]: Zhang et al., 2012. Toxicological Sciences
Teratogens

Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

Summary

3 missclassified out of 33

TOTAL: 10 out of 59
Simplified WEC Assay
Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

Summary

x 100 = 83%

14
RP: Recursive Partitioning

70
[4]: Zhang et al., 2012. Toxicological Sciences
Summary
Whole Embryo Culture

DB-ALM report

Simplified WEC Assay

Summary

Simplified study design
Simplified data analysis
Prediction model does not require
cytotoxicity data from a cell line
No significant reduction in predictivity
50 % reduction of animal use and operational costs

What do you
want from
me?

Substance related mechanistical studies  ECVAM protocol n.123

Simplified version  Screening or priority testing

Zhang et al., 2012. Toxicological Sciences
Whole Embryo Culture

Thank you

DB-ALM report

Simplified WEC Assay

Summary

Gràcies

Mais conteúdo relacionado

Mais procurados

The Role of Bioinformatics in The Drug Discovery Process
The Role of Bioinformatics in The Drug Discovery ProcessThe Role of Bioinformatics in The Drug Discovery Process
The Role of Bioinformatics in The Drug Discovery ProcessAdebowale Qazeem
 
Tosk’s Fruit Fly Models Used in Discovering New Cancer Drug Therapies
Tosk’s Fruit Fly Models Used in Discovering New Cancer Drug TherapiesTosk’s Fruit Fly Models Used in Discovering New Cancer Drug Therapies
Tosk’s Fruit Fly Models Used in Discovering New Cancer Drug TherapiesBrianFrenzel
 
In vitro data and in silico models for predictive toxicology
In vitro data and in silico models for predictive toxicologyIn vitro data and in silico models for predictive toxicology
In vitro data and in silico models for predictive toxicologyEFSA EU
 
SMR kinase meeting October 2013
SMR kinase meeting October 2013SMR kinase meeting October 2013
SMR kinase meeting October 2013jpoverington
 
High School Career Day Drug Development 2010
High School Career Day Drug Development 2010High School Career Day Drug Development 2010
High School Career Day Drug Development 2010Insiteqa
 
Clinical research Overview ppt
Clinical research Overview pptClinical research Overview ppt
Clinical research Overview pptAcri India
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drugswati2084
 
Estimating bioactivity database error rates, tiikkainen
Estimating bioactivity database error rates, tiikkainenEstimating bioactivity database error rates, tiikkainen
Estimating bioactivity database error rates, tiikkainenPekka Tiikkainen
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testingpriyachhikara1
 
In vitro and high throughput screening (HTS) assays
In vitro and high throughput screening (HTS) assaysIn vitro and high throughput screening (HTS) assays
In vitro and high throughput screening (HTS) assaysEFSA EU
 
Drug Discovery - The Origin of New Chemical Entity Pharmaceuticals
Drug Discovery - The Origin of New Chemical Entity PharmaceuticalsDrug Discovery - The Origin of New Chemical Entity Pharmaceuticals
Drug Discovery - The Origin of New Chemical Entity PharmaceuticalsMaRS Discovery District
 
Predictive tox proposal_ver1
Predictive tox proposal_ver1Predictive tox proposal_ver1
Predictive tox proposal_ver1Ankur Khanna
 
Research Avenues in Drug discovery of natural products
Research Avenues in Drug discovery of natural productsResearch Avenues in Drug discovery of natural products
Research Avenues in Drug discovery of natural productsDevakumar Jain
 
Drug discovery strategy final draft
Drug discovery strategy   final draftDrug discovery strategy   final draft
Drug discovery strategy final draftanaelishockey
 
Steven_Chico resume
Steven_Chico resumeSteven_Chico resume
Steven_Chico resumeSteven Chico
 
Sagar alone qsar studies of saponin analogues for anticancer activity
Sagar alone  qsar studies of saponin analogues for anticancer activitySagar alone  qsar studies of saponin analogues for anticancer activity
Sagar alone qsar studies of saponin analogues for anticancer activitysagar alone
 
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...Sean Ekins
 
Predictive comparative qsar analysis of as 5 nitrofuran-2-yl derivatives myco...
Predictive comparative qsar analysis of as 5 nitrofuran-2-yl derivatives myco...Predictive comparative qsar analysis of as 5 nitrofuran-2-yl derivatives myco...
Predictive comparative qsar analysis of as 5 nitrofuran-2-yl derivatives myco...hiij
 

Mais procurados (20)

The Role of Bioinformatics in The Drug Discovery Process
The Role of Bioinformatics in The Drug Discovery ProcessThe Role of Bioinformatics in The Drug Discovery Process
The Role of Bioinformatics in The Drug Discovery Process
 
Presenatation on insillico drug design
Presenatation on insillico drug designPresenatation on insillico drug design
Presenatation on insillico drug design
 
Tosk’s Fruit Fly Models Used in Discovering New Cancer Drug Therapies
Tosk’s Fruit Fly Models Used in Discovering New Cancer Drug TherapiesTosk’s Fruit Fly Models Used in Discovering New Cancer Drug Therapies
Tosk’s Fruit Fly Models Used in Discovering New Cancer Drug Therapies
 
In vitro data and in silico models for predictive toxicology
In vitro data and in silico models for predictive toxicologyIn vitro data and in silico models for predictive toxicology
In vitro data and in silico models for predictive toxicology
 
SMR kinase meeting October 2013
SMR kinase meeting October 2013SMR kinase meeting October 2013
SMR kinase meeting October 2013
 
Docking
DockingDocking
Docking
 
High School Career Day Drug Development 2010
High School Career Day Drug Development 2010High School Career Day Drug Development 2010
High School Career Day Drug Development 2010
 
Clinical research Overview ppt
Clinical research Overview pptClinical research Overview ppt
Clinical research Overview ppt
 
Development mol drug
Development mol drugDevelopment mol drug
Development mol drug
 
Estimating bioactivity database error rates, tiikkainen
Estimating bioactivity database error rates, tiikkainenEstimating bioactivity database error rates, tiikkainen
Estimating bioactivity database error rates, tiikkainen
 
Alternative methods to animal toxicity testing
Alternative methods to animal toxicity testingAlternative methods to animal toxicity testing
Alternative methods to animal toxicity testing
 
In vitro and high throughput screening (HTS) assays
In vitro and high throughput screening (HTS) assaysIn vitro and high throughput screening (HTS) assays
In vitro and high throughput screening (HTS) assays
 
Drug Discovery - The Origin of New Chemical Entity Pharmaceuticals
Drug Discovery - The Origin of New Chemical Entity PharmaceuticalsDrug Discovery - The Origin of New Chemical Entity Pharmaceuticals
Drug Discovery - The Origin of New Chemical Entity Pharmaceuticals
 
Predictive tox proposal_ver1
Predictive tox proposal_ver1Predictive tox proposal_ver1
Predictive tox proposal_ver1
 
Research Avenues in Drug discovery of natural products
Research Avenues in Drug discovery of natural productsResearch Avenues in Drug discovery of natural products
Research Avenues in Drug discovery of natural products
 
Drug discovery strategy final draft
Drug discovery strategy   final draftDrug discovery strategy   final draft
Drug discovery strategy final draft
 
Steven_Chico resume
Steven_Chico resumeSteven_Chico resume
Steven_Chico resume
 
Sagar alone qsar studies of saponin analogues for anticancer activity
Sagar alone  qsar studies of saponin analogues for anticancer activitySagar alone  qsar studies of saponin analogues for anticancer activity
Sagar alone qsar studies of saponin analogues for anticancer activity
 
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...
Collaborative Drug Discovery: A Platform For Transforming Neglected Disease R...
 
Predictive comparative qsar analysis of as 5 nitrofuran-2-yl derivatives myco...
Predictive comparative qsar analysis of as 5 nitrofuran-2-yl derivatives myco...Predictive comparative qsar analysis of as 5 nitrofuran-2-yl derivatives myco...
Predictive comparative qsar analysis of as 5 nitrofuran-2-yl derivatives myco...
 

Destaque

Destaque (13)

OMICS (Ivo gut)
OMICS (Ivo gut)OMICS (Ivo gut)
OMICS (Ivo gut)
 
Discovering drugs (I. Belda)
Discovering drugs (I. Belda)Discovering drugs (I. Belda)
Discovering drugs (I. Belda)
 
Organismos modificados geneticamente (X. Cañas)
Organismos modificados geneticamente (X. Cañas)Organismos modificados geneticamente (X. Cañas)
Organismos modificados geneticamente (X. Cañas)
 
The in vitro choice j sendra_2013
The in vitro choice j sendra_2013The in vitro choice j sendra_2013
The in vitro choice j sendra_2013
 
The in vitro choice_O.Nicolas_2013
The in vitro choice_O.Nicolas_2013The in vitro choice_O.Nicolas_2013
The in vitro choice_O.Nicolas_2013
 
The in vitro choice ellen iuf 2013
The in vitro choice ellen iuf 2013The in vitro choice ellen iuf 2013
The in vitro choice ellen iuf 2013
 
Toxicidad in vitro (J. de Lapuente)
Toxicidad in vitro (J. de Lapuente)Toxicidad in vitro (J. de Lapuente)
Toxicidad in vitro (J. de Lapuente)
 
The in vitro choice_ P.Vinardell_2013
The in vitro choice_ P.Vinardell_2013The in vitro choice_ P.Vinardell_2013
The in vitro choice_ P.Vinardell_2013
 
The in vitro choice_ MBorras_2013
The in vitro choice_ MBorras_2013The in vitro choice_ MBorras_2013
The in vitro choice_ MBorras_2013
 
La figura del Toxicologo dentro de la cosmetica (C. Campos)
La figura del Toxicologo dentro de la cosmetica (C. Campos)La figura del Toxicologo dentro de la cosmetica (C. Campos)
La figura del Toxicologo dentro de la cosmetica (C. Campos)
 
Preclinical development (C. Salcedo)
Preclinical development (C. Salcedo)Preclinical development (C. Salcedo)
Preclinical development (C. Salcedo)
 
The in vitro choice d ramos-2013
The in vitro choice   d ramos-2013The in vitro choice   d ramos-2013
The in vitro choice d ramos-2013
 
The in vitro choice_M.Dusinska_2013
The in vitro choice_M.Dusinska_2013The in vitro choice_M.Dusinska_2013
The in vitro choice_M.Dusinska_2013
 

Semelhante a The in vitro choice m barenys iuf_2013

Eficacia de poractan vs beractan en sra metanalisis
Eficacia de poractan vs beractan en sra metanalisisEficacia de poractan vs beractan en sra metanalisis
Eficacia de poractan vs beractan en sra metanalisisMauricio Piñeros
 
Edc april june2012_overview
Edc april june2012_overviewEdc april june2012_overview
Edc april june2012_overviewHoa Hoàng
 
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL TO HUMANS
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL TO HUMANS EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL TO HUMANS
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL TO HUMANS KARNATAKA COLLEGE OF PHARMACY
 
Best compound characterization protocol
Best compound characterization protocolBest compound characterization protocol
Best compound characterization protocolWenlan Hu
 
Alternative animal model for compound characterization
Alternative animal model for compound characterizationAlternative animal model for compound characterization
Alternative animal model for compound characterizationWenlan Hu
 
toxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdftoxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdfChijiokeNsofor
 
Mode of action analysis
Mode of action analysisMode of action analysis
Mode of action analysisWenlan Hu
 
Postnatal Evaluation in Developmental and Juvenile Toxicity Studies
Postnatal Evaluation in Developmental and Juvenile Toxicity StudiesPostnatal Evaluation in Developmental and Juvenile Toxicity Studies
Postnatal Evaluation in Developmental and Juvenile Toxicity StudiesJoseph Holson
 
Good Model Organism for Anti Aging Testing
Good Model Organism for Anti Aging TestingGood Model Organism for Anti Aging Testing
Good Model Organism for Anti Aging TestingWenlan Hu
 
Finding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging DrugsFinding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging DrugsWenlan Hu
 
International Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity StudiesInternational Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity StudiesSuneal Saini
 
chronic toxicity studies
chronic toxicity studieschronic toxicity studies
chronic toxicity studieskaran chainani
 
How to model longevity and health effect in 3 months
How to model longevity and health effect in 3 monthsHow to model longevity and health effect in 3 months
How to model longevity and health effect in 3 monthsWenlan Hu
 
Overview of OECD Test Guidelines for Thyroid Effects
Overview of OECD Test Guidelines for Thyroid EffectsOverview of OECD Test Guidelines for Thyroid Effects
Overview of OECD Test Guidelines for Thyroid EffectsOECD Environment
 
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoeaSaccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoeaUtai Sukviwatsirikul
 
Systematic review with meta-analysis: Saccharomyces boulardii in the preventi...
Systematic review with meta-analysis: Saccharomyces boulardii in the preventi...Systematic review with meta-analysis: Saccharomyces boulardii in the preventi...
Systematic review with meta-analysis: Saccharomyces boulardii in the preventi...Utai Sukviwatsirikul
 
Using available tools for tiered assessments and rapid MoE
Using available tools for tiered assessments and rapid MoEUsing available tools for tiered assessments and rapid MoE
Using available tools for tiered assessments and rapid MoERebeccaClewell
 

Semelhante a The in vitro choice m barenys iuf_2013 (20)

Eficacia de poractan vs beractan en sra metanalisis
Eficacia de poractan vs beractan en sra metanalisisEficacia de poractan vs beractan en sra metanalisis
Eficacia de poractan vs beractan en sra metanalisis
 
Edc april june2012_overview
Edc april june2012_overviewEdc april june2012_overview
Edc april june2012_overview
 
Singh et al., 2011
Singh et al., 2011Singh et al., 2011
Singh et al., 2011
 
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL TO HUMANS
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL TO HUMANS EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL TO HUMANS
EXTRAPOLATION OF IN VITRO DATA TO PRECLINICAL TO HUMANS
 
Best compound characterization protocol
Best compound characterization protocolBest compound characterization protocol
Best compound characterization protocol
 
Alternative animal model for compound characterization
Alternative animal model for compound characterizationAlternative animal model for compound characterization
Alternative animal model for compound characterization
 
toxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdftoxicitytesting-200920120607.pdf
toxicitytesting-200920120607.pdf
 
Mode of action analysis
Mode of action analysisMode of action analysis
Mode of action analysis
 
Postnatal Evaluation in Developmental and Juvenile Toxicity Studies
Postnatal Evaluation in Developmental and Juvenile Toxicity StudiesPostnatal Evaluation in Developmental and Juvenile Toxicity Studies
Postnatal Evaluation in Developmental and Juvenile Toxicity Studies
 
Good Model Organism for Anti Aging Testing
Good Model Organism for Anti Aging TestingGood Model Organism for Anti Aging Testing
Good Model Organism for Anti Aging Testing
 
Finding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging DrugsFinding Optimal Compound Dosage for Anti-Aging Drugs
Finding Optimal Compound Dosage for Anti-Aging Drugs
 
Phase 1 protocol
Phase 1 protocolPhase 1 protocol
Phase 1 protocol
 
International Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity StudiesInternational Guidelines and Regulatory Agencies for Toxicity Studies
International Guidelines and Regulatory Agencies for Toxicity Studies
 
chronic toxicity studies
chronic toxicity studieschronic toxicity studies
chronic toxicity studies
 
Animal toxicity studies
Animal toxicity studiesAnimal toxicity studies
Animal toxicity studies
 
How to model longevity and health effect in 3 months
How to model longevity and health effect in 3 monthsHow to model longevity and health effect in 3 months
How to model longevity and health effect in 3 months
 
Overview of OECD Test Guidelines for Thyroid Effects
Overview of OECD Test Guidelines for Thyroid EffectsOverview of OECD Test Guidelines for Thyroid Effects
Overview of OECD Test Guidelines for Thyroid Effects
 
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoeaSaccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
Saccharomyces boulardii in the prevention of antibiotic-associated diarrhoea
 
Systematic review with meta-analysis: Saccharomyces boulardii in the preventi...
Systematic review with meta-analysis: Saccharomyces boulardii in the preventi...Systematic review with meta-analysis: Saccharomyces boulardii in the preventi...
Systematic review with meta-analysis: Saccharomyces boulardii in the preventi...
 
Using available tools for tiered assessments and rapid MoE
Using available tools for tiered assessments and rapid MoEUsing available tools for tiered assessments and rapid MoE
Using available tools for tiered assessments and rapid MoE
 

Mais de La unidad de Toxicología Experimental y Ecotoxicología (UTOX-PCB)

Mais de La unidad de Toxicología Experimental y Ecotoxicología (UTOX-PCB) (15)

Programa Jornada The in vitro Choice 29 Noviembre 2013
Programa Jornada The in vitro Choice 29 Noviembre 2013Programa Jornada The in vitro Choice 29 Noviembre 2013
Programa Jornada The in vitro Choice 29 Noviembre 2013
 
cosmetic safety raport
cosmetic safety raportcosmetic safety raport
cosmetic safety raport
 
El papel de los consultores en el desarrollo preclínico (E. Cunchillos)
El papel de los consultores en el desarrollo preclínico (E. Cunchillos)El papel de los consultores en el desarrollo preclínico (E. Cunchillos)
El papel de los consultores en el desarrollo preclínico (E. Cunchillos)
 
Seguridad en el desarrollo de Fármacos (A. Guzman)
Seguridad en el desarrollo de Fármacos (A. Guzman)Seguridad en el desarrollo de Fármacos (A. Guzman)
Seguridad en el desarrollo de Fármacos (A. Guzman)
 
Toxicidad in vivo (M. Borràs)
Toxicidad in vivo (M. Borràs)Toxicidad in vivo (M. Borràs)
Toxicidad in vivo (M. Borràs)
 
Seguridad Alimentaria (JM. Llobet)
Seguridad Alimentaria (JM. Llobet)Seguridad Alimentaria (JM. Llobet)
Seguridad Alimentaria (JM. Llobet)
 
Cell Transformation assay CTA (D. Ramos)
Cell Transformation assay CTA (D. Ramos)Cell Transformation assay CTA (D. Ramos)
Cell Transformation assay CTA (D. Ramos)
 
Exotoxicologia en medicamentos (J. Gonzalez)
Exotoxicologia en medicamentos (J. Gonzalez)Exotoxicologia en medicamentos (J. Gonzalez)
Exotoxicologia en medicamentos (J. Gonzalez)
 
Jornada tox® Programa
Jornada tox® ProgramaJornada tox® Programa
Jornada tox® Programa
 
Reglamento 640 2012 sobre ensayos REACH
Reglamento 640 2012 sobre ensayos REACHReglamento 640 2012 sobre ensayos REACH
Reglamento 640 2012 sobre ensayos REACH
 
Ficha veterinaria (castellano)
Ficha veterinaria (castellano)Ficha veterinaria (castellano)
Ficha veterinaria (castellano)
 
Ficha medical device (castellano)
Ficha medical device (castellano)Ficha medical device (castellano)
Ficha medical device (castellano)
 
Ficha farma & biotec (castellano)
Ficha farma & biotec (castellano)Ficha farma & biotec (castellano)
Ficha farma & biotec (castellano)
 
Ficha cosmética (castellano)
Ficha cosmética (castellano)Ficha cosmética (castellano)
Ficha cosmética (castellano)
 
Ficha alimentación
Ficha alimentaciónFicha alimentación
Ficha alimentación
 

Último

Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Falcon Invoice Discounting
 
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...meghakumariji156
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptxnandhinijagan9867
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSpanmisemningshen123
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdflaloo_007
 
Power point presentation on enterprise performance management
Power point presentation on enterprise performance managementPower point presentation on enterprise performance management
Power point presentation on enterprise performance managementVaishnaviGunji
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAITim Wilson
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxCynthia Clay
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...NadhimTaha
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingNauman Safdar
 
Falcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to ProsperityFalcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to Prosperityhemanthkumar470700
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfAdmir Softic
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecZurliaSoop
 
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannaBusinessPlans
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGpr788182
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Adnet Communications
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPanhandleOilandGas
 

Último (20)

Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
Unveiling Falcon Invoice Discounting: Leading the Way as India's Premier Bill...
 
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
Escorts in Nungambakkam Phone 8250092165 Enjoy 24/7 Escort Service Enjoy Your...
 
Phases of Negotiation .pptx
 Phases of Negotiation .pptx Phases of Negotiation .pptx
Phases of Negotiation .pptx
 
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NSCROSS CULTURAL NEGOTIATION BY PANMISEM NS
CROSS CULTURAL NEGOTIATION BY PANMISEM NS
 
Structuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdfStructuring and Writing DRL Mckinsey (1).pdf
Structuring and Writing DRL Mckinsey (1).pdf
 
Power point presentation on enterprise performance management
Power point presentation on enterprise performance managementPower point presentation on enterprise performance management
Power point presentation on enterprise performance management
 
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAIGetting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
Getting Real with AI - Columbus DAW - May 2024 - Nick Woo from AlignAI
 
Putting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptxPutting the SPARK into Virtual Training.pptx
Putting the SPARK into Virtual Training.pptx
 
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pillsMifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
Mifty kit IN Salmiya (+918133066128) Abortion pills IN Salmiyah Cytotec pills
 
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...joint cost.pptx  COST ACCOUNTING  Sixteenth Edition                          ...
joint cost.pptx COST ACCOUNTING Sixteenth Edition ...
 
Mckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for ViewingMckinsey foundation level Handbook for Viewing
Mckinsey foundation level Handbook for Viewing
 
Falcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to ProsperityFalcon's Invoice Discounting: Your Path to Prosperity
Falcon's Invoice Discounting: Your Path to Prosperity
 
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdfDr. Admir Softic_ presentation_Green Club_ENG.pdf
Dr. Admir Softic_ presentation_Green Club_ENG.pdf
 
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan CytotecJual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
Jual Obat Aborsi ( Asli No.1 ) 085657271886 Obat Penggugur Kandungan Cytotec
 
Buy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail AccountsBuy gmail accounts.pdf buy Old Gmail Accounts
Buy gmail accounts.pdf buy Old Gmail Accounts
 
Cannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 UpdatedCannabis Legalization World Map: 2024 Updated
Cannabis Legalization World Map: 2024 Updated
 
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDINGParadip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
Paradip CALL GIRL❤7091819311❤CALL GIRLS IN ESCORT SERVICE WE ARE PROVIDING
 
Falcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investorsFalcon Invoice Discounting: The best investment platform in india for investors
Falcon Invoice Discounting: The best investment platform in india for investors
 
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
Lundin Gold - Q1 2024 Conference Call Presentation (Revised)
 
PHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation FinalPHX May 2024 Corporate Presentation Final
PHX May 2024 Corporate Presentation Final
 

The in vitro choice m barenys iuf_2013

  • 1. The simplified Whole Embryo Culture the throughput increase of a validated tool for developmental toxicology Marta Barenys CERETOX – Centre de Recerca en Toxicologia, Parc Científic de Barcelona IUF – Leibniz Research Institute for Environmental Medicine, Düsseldorf
  • 2. Outline Whole Embryo Culture DB-ALM report Simplified WEC Assay Summary
  • 3. Whole Embryo Culture (WEC) developmental toxicology Whole Embryo Culture Implantation DB-ALM report WEC WEC Fetal - period Organogenesis Simplified WEC Assay Summary 0 2 4 6 8 10 12 14 16 18 Gestational Day Establishment: New, 1978. Biol Rev Camb Philos Soc REACH - Registration, Evaluation, Authorization and Restriction of Chemicals ECVAM Validation: Genschow et al., 2002. Altern Lab Anim Piersma et al., 2004. Altern Lab Anim ECVAM DB-ALM Protocol n.123 – Method of Piersma 20 21
  • 4. [1] Whole Embryo Culture DB-ALM report Simplified WEC Assay Summary [1]:Flick and Klug, 2006. Curr Pharm Des
  • 5. 48 h Whole Embryo Culture DB-ALM report Simplified WEC Assay Summary Isolation Culture Evaluation Gestational Day 9.5 37ºC temperature 25 rpm rotation Endpoints: Tested substances added to the culture medium Oxygenation Viability Growth Differentiation Malformations
  • 6. „a demanding procedure which might be unsuitable for routine use as a first step in a large scale screening program“ Evaluation Whole Embryo Culture Crown-rump length DB-ALM report Somite number Simplified WEC Assay Summary Total Morphological Score: Malformations ICmax mal ICNOEC TMS ECVAM Prediction Model 2 IC50 3T3 A. B. C. D. E. F. G. H. J. K. L. M. N. P. Q. R. Yolk sac and blood vessels Allantois Flexion Heart Caudal neural tube Hind brain Mid brain Fore brain Otic system Optic system Olfactory system Branchial bars Maxillary process Mandibular process Fore limb Hind limb I > II & III = non embryotoxic II > I & III = weak embryotoxic III > I & II = strong embryotoxic
  • 7. [2] Whole Embryo Culture DB-ALM report Simplified WEC Assay Summary 1 mm CERETOX Developmental toxicity studies: - among compounds of the same family - among parent compound and metabolites de Jong et al., 2011 Toxicol Appl Pharmacol Barenys et al., 2012 Reprod Toxicol Boix et al., in preparation [2]: Barenys et al., 2012. Reprod Toxicol
  • 8. European Partnership for Alternative Approaches to Animal Testing (EPAA) Whole Embryo Culture DB-ALM report Simplified WEC Assay Summary Questionnaire survey - Alternative methods for reproductive toxicity testing Aim: to investigate the real use of each alternative method among industries Participants: 11 large international pharmaceutical and chemical companies ECVAM DataBase service on Alternative Methods to animal experimentation (DB-ALM) DB-ALM reproductive toxicity report 2011[3] [3]:http://ec.europa.eu/enterprise/epaa/2_activities/2_3_comm_and_ dissem/report_alternative_methods_reproductive_toxicity_testing.pdf
  • 9. DB-ALM report Alternative methods for reproductive toxicity testing Whole Embryo Culture 39 21 9 total DB-ALM report developmental toxicity really used ZFET - Zebrafish Embryo Test EST - Embryonic Stem Cell Test WEC - Whole Embryo Culture Simplified WEC Assay Summary WEC: 6 companies substance related mechanistic studies screening or priority testing regulatory purposes studies on species differences (rat/rabbit) part of integrated testing strategy or stand-alone test [3]:http://ec.europa.eu/enterprise/epaa/2_activities/2_3_comm_and_ dissem/report_alternative_methods_reproductive_toxicity_testing.pdf
  • 10. Advantages: Whole Embryo Culture DB-ALM report Simplified WEC Assay Whole organism Same species than in in vivo reproductive toxicity assays High predictivity High reproducibility Summary Disadvantages: High expertise required High cost Labor intensive Low throughput Should I stay or should I go?
  • 11. Simplified WEC Assay [4] Whole Embryo Culture DB-ALM report Simplified WEC Assay All compounds Spinal cord ≥ 4.83? Aims: ↑ throughput ↓ animal use without reducing predictivity Yes No Heart ≥ 4.75? Teratogen Yes No Nonteratogen N° of somites ≥ 22.575? Summary Simplification achieved by: No Statistical prediction model supported by Teratogen one test concentration two structural endpoints (spinal cord – heart) one growth endpoint (n. of somites) Yes Nonteratogen Prediction model built with data from: 59 compounds (33 teratogens and 26 nonteratogens) 70 +11 compounds ( 5t & 6nt) for independent validation [4]: Zhang et al., 2012. Toxicological Sciences
  • 12. Simplified WEC Assay Nonteratogens Whole Embryo Culture DB-ALM report Simplified WEC Assay Summary Results from 3 independent laboratories Average scores obtained from two or more experiments with six embryos per experiment 7 missclassified out of 26 [4]: Zhang et al., 2012. Toxicological Sciences
  • 13. Teratogens Whole Embryo Culture DB-ALM report Simplified WEC Assay Summary 3 missclassified out of 33 TOTAL: 10 out of 59
  • 14. Simplified WEC Assay Whole Embryo Culture DB-ALM report Simplified WEC Assay Summary x 100 = 83% 14 RP: Recursive Partitioning 70 [4]: Zhang et al., 2012. Toxicological Sciences
  • 15. Summary Whole Embryo Culture DB-ALM report Simplified WEC Assay Summary Simplified study design Simplified data analysis Prediction model does not require cytotoxicity data from a cell line No significant reduction in predictivity 50 % reduction of animal use and operational costs What do you want from me? Substance related mechanistical studies  ECVAM protocol n.123 Simplified version  Screening or priority testing Zhang et al., 2012. Toxicological Sciences
  • 16. Whole Embryo Culture Thank you DB-ALM report Simplified WEC Assay Summary Gràcies